About Survey Partners
The Futures Company delivers measurable breakthroughs in marketing productivity for Fortune 500 clients. We identify for our clients specific, tangible opportunities for competitive advantage by moving them from simplistic targeting to advanced productivity solutions. The Futures Company was established in 2008 with the merger of Yankelovich, Inc., and Henley Centre HeadlightVision, creating an unparalleled global consultancy powered by unique database and segmentation solutions and unparalleled information-based insights into consumer motivations and lifestyles.
About Duramed Pharmaceuticals, Inc. (Now Teva Women's Health, Inc.)
Duramed Pharmaceuticals, Inc., (now Teva Women's Health, Inc.) which develops and markets proprietary pharmaceutical products in North America, focuses primarily on products for women and emphasizes the development and marketing of products for reproductive and menopausal needs. Currently, Duramed markets 27 proprietary pharmaceutical products.
Duramed is a subsidiary of Teva Pharmaceutical Industries Ltd. Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the world's leading generic pharmaceutical company. The Company develops, manufactures and markets generic and innovative human pharmaceuticals and active pharmaceutical ingredients, as well as animal health pharmaceutical products. Over 80 percent of Teva's sales are in North America and Europe.
|SOURCE Teva Women's Health, Inc.|
Copyright©2009 PR Newswire.
All rights reserved